ITALIANO, DOMENICO
 Distribuzione geografica
Continente #
NA - Nord America 1.769
EU - Europa 1.426
AS - Asia 332
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 3.533
Nazione #
US - Stati Uniti d'America 1.767
IE - Irlanda 478
SE - Svezia 459
CN - Cina 276
IT - Italia 115
UA - Ucraina 106
DE - Germania 94
FI - Finlandia 79
GB - Regno Unito 46
IN - India 44
BE - Belgio 22
PL - Polonia 10
AT - Austria 6
FR - Francia 6
IR - Iran 5
JO - Giordania 3
NL - Olanda 3
CA - Canada 2
EU - Europa 2
NZ - Nuova Zelanda 2
RU - Federazione Russa 2
VN - Vietnam 2
AU - Australia 1
EG - Egitto 1
IL - Israele 1
JP - Giappone 1
Totale 3.533
Città #
Dublin 478
Chandler 382
Jacksonville 245
Nyköping 172
Beijing 134
Houston 123
Cambridge 79
Princeton 79
Medford 75
Ashburn 70
Des Moines 65
Ann Arbor 59
Dearborn 51
Boardman 42
Messina 35
San Mateo 27
Pune 25
Brussels 22
Jinan 20
Shenyang 20
Lancaster 16
Wilmington 16
Woodbridge 15
Hyderabad 13
Haikou 10
Ningbo 10
Tianjin 10
Warsaw 10
Taizhou 9
Zhengzhou 9
Hebei 8
Nanjing 8
Rome 8
Vienna 6
Augusta 5
Los Angeles 5
Mountain View 5
New York 5
Trezzo 5
Arlington 4
Catania 4
Guangzhou 4
Hangzhou 4
Lanzhou 4
Leawood 4
Mascali 4
Seattle 4
Albuquerque 3
Alessandria 3
Amman 3
Ardabil 3
Bremen 3
Charlotte 3
Monmouth Junction 3
Mumbai 3
Nanchang 3
Norwalk 3
Taiyuan 3
Castrolibero 2
Changsha 2
Civate 2
Dong Ket 2
Florence 2
Foggia 2
Helsinki 2
Milan 2
Munich 2
Noto 2
Salerno 2
Selvazzano Dentro 2
Shenzhen 2
Strasbourg 2
Tappahannock 2
Washington 2
Xiangfen 2
Amsterdam 1
Baotou 1
Cagliari 1
Cairo 1
Caltagirone 1
Carini 1
Chengdu 1
Chieti 1
Clearwater 1
Como 1
Cupertino 1
Dallas 1
Fuzhou 1
Hefei 1
Jiaxing 1
Kashan 1
Milazzo 1
Nanning 1
Novokuznetsk 1
Olgiate Olona 1
Ospedaletto Euganeo 1
Ottawa 1
Pescara 1
Piedimonte Etneo 1
Quartu Sant'elena 1
Totale 2.500
Nome #
Description of a family with a novel progressive myoclonus epilepsy and cognitive impairment. 149
Head-to-Head Comparison of Aripiprazole and Risperidone in the Treatment of ADHD Symptoms in Children with Autistic Spectrum Disorder and ADHD: A Pilot, Open-Label, Randomized Controlled Study 118
Targeting Toll-like receptors: emerging therapeutics for multiple sclerosis management. 67
Generic Olanzapine Substitution in Patients with Schizophrenia: Assessment of Serum Concentrations and Therapeutic Response After Switching 66
Antiepileptic drugs and MTHFR Polymorphisms influence hyper-homocysteinemia recurrence in epileptic patients 64
Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011 62
“Description of a four-generation family with autosomal dominant cerebellar ataxia: clinical and genetic analysis” 62
Glutamine-supplemented total parenteral nutrition improves immunological status in anorectic patients 61
Difficulty in making differential diagnosis of recurrent occipital seizures in a patient with symptoms of status migrainosus: a case report. 60
Glutamine treatment attenuates the development of ischaemia/reperfusion injury of the gut. 60
Antiepileptic drugs and MTHFR mutations affect hyperhomocysteinemia rate in epileptic patients. 59
Does lacosamide aggravate Lennox-Gastaut syndrome? Report on three consecutive cases. 58
Expanding the global prevalence of spinocerebellar ataxia type 42 58
Description of a family with probable autosomal dominant progressive myoclonus epilepsy and cognitive impairment 57
Lennox Gastaut Syndrome in Adulthood: clinical and EEG features 57
Description of a four-generation family with autosomal dominant cerebellar ataxia: clinical and genetic analysis. 57
Complications of trauma patients admitted to the ICU in level i academic trauma centers in the United States 56
Glutamine treatment attenuates the development of organ injury induced by zymosan administration in mice 55
Omocisteina ed epilessia. 54
Description of a four-generation family with autosomal dominant cerebellar ataxia: clinical and genetic analysis. 54
A pilot open-label trial of zonisamide in Unverricht-Lundborg disease 54
ECG parameters in children and adolescents treated with aripiprazole and risperidone 54
Description of a family with a novel progressive myoclonus epilepsy and cognitive impairment. 53
Clinical and EEG features of Lennox-Gastaut syndrome in adulthood 53
Neuropsychological findings in patients with Unverricht-Lundborg disease. 52
Dose-dependent oxcarbazepine-related anorgasmia 52
CLINICAL AND GENETIC STUDY OF AN ITALIAN FAMILY WITH SPINOCEREBELLAR ATAXIA TYPE 7 52
Effects of aripiprazole and risperidone on ventricular repolarization in children and adolescent. 50
Clinical and genetic analysis of a four-generation family with autosomal dominant spinocerebellar ataxia 49
The C677T/A128C MTHFR diplotype, antiepileptic medication and the risk of hyperhomocysteinemia in patients with epilepsy. 48
Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with Attention Deficit Hyperactivity Disorder 48
Le nuove opzioni terapeutiche nel trattamento dell'epilessia. 47
AUTOPHAGY DEREGULATION: A POTENTIAL KEY FACTOR IN THE PATHOGENESIS OF PARKINSON’S DISEASE, 47
Dose-dependent oxcarbazepine-induced anorgasmia 46
CSF and Plasma Amyloid-b Temporal Profiles and Relationships with Neurological Status and Mortality after Severe Traumatic Brain Injury: Results of a Pilot Study 46
When transient psychiatric and neurological symtoms mingle in the same patient and breed “the trick of the trade”: two case report. 45
Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats 45
Description of a four-generation family with autosomal dominant cerebellar ataxia: clinical and genetic analysis. 44
The hypothalamic-neurohypophyseal system: current and future treatment of vasopressin and oxytocyn related disorders. 42
MTHFR polymorphisms and antiepileptic medication influence the therapeutic schedule of folate supplementation in epileptic patient on hyperhomocysteinemia. 41
Efficacy and tolerability of zonisamide (Zonegran) in ULD: a pilot open-label-study. 41
Lennox-Gastaut syndrome in adulthood: clinical and EEG features. 41
The Challenge of Mild Traumatic Brain Injury: Role of Biochemical Markers in Diagnosis of Brain Damage. 41
Spinocerebellar ataxia type 7: report of a new Italian family. 41
Valutazione degli effetti cardiovascolari acuti del metilfenidato a rilascio immediato in bambini ed adolescenti con Disturbo da Deficit d’Attenzione ed Iperattività 41
Sexuality in other neuropsychiatric disorders. 40
Topiramate-induced erectile dysfunction 40
Single tonic-clonic seizure after energy drink abuse. 40
Famiglia con convulsioni neonatali benigne 39
Olanzapine treatment improved quality of life in a patient with fibromyalgia syndrome: a psychological evaluation. 39
Valutazione degli effetti cardiovascolari acuti del metilfenidato a rilascio immediato in bambini ed adolescenti con ADHD 39
Effectiveness of risk minimization measures for cabergoline-induced cardiac valve fibrosis in clinical practice in Italy 39
Relationship between serum mono-hydroxy-carbazepine concentrations and adverseeffects in patients with epilepsy on high-dose oxcarbazepine therapy. 38
Horner syndrome following thyroidectomy 38
Quality of life assessments with SF 36 in fibromyalgia: case report. 38
Protective effect of apocynin, a NADPH-oxidase inhibitor, against contrast-induced nephropathy in the diabetic rats: a comparison with n-acetylcysteine. 38
USO DI AGONISTI DEL TLR3 COME VACCINI PER IL TRATTAMENTO DELLA SCLEROSI MULTIPLA 37
Recurrent occipital seizures misdiagnosed as status migrainosus. 36
INDIVIDUATION OF BIOMARKERS IN AMYOTROPHIC LATERAL SCLEROSIS 36
TOPIRAMATE INDUCED SEXUAL DYSFUNCTION 35
TARGETING TOLL-LIKE RECEPTROS: EMERGING THERAPEUTICS FOR MULTIPLE SCLEROSIS MANAGEMENT 33
Genetics of reflex seizures and epilepsies in humans and animals 33
Neuropsychological findings in patients with Unverricht-Lundborg disease. 33
Zonisamide-related erectile dysfunction 32
Erythropoietin suppresses peritoneal fibrosis in rat experimental model. 31
Can zinc depletion play a role in LEV-induced hair loss? Considerations from a case study. 31
Serum MHD monitoring may be usefull in the management of side effects in epileptic patients on high doses of oxcarbazepine. 29
Effects of Apocynin, A Nadph-oxidase Inhibitor, In Contrast-induced Nephropathy 29
Minor and repetitive head injury 28
Horner syndrome as a complication of thyroidal disease and surgery: report of two cases. 28
α-Synuclein in CSF of patients with severe traumatic brain injury. 27
Generalized versus partial reflex seizures: a review. 26
Ketotifen-induced nocturnal bruxism 23
Oxcarbazepine-related retrograde ejaculation. 22
null 21
Psychogenic itch responding to topiramate. 21
Levetiracetam-associated loss of libido and anhedonia. 19
The hypothalamic-neurohypophyseal system: current and future treatment of vasopressin and oxytocyn related disorders. 18
Horner syndrome following thyroidectomy. 16
Recurrent occipital seizures misdiagnosed as status migrainosus. 13
Totale 3.592
Categoria #
all - tutte 13.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.006


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 0 1
2019/2020568 48 19 1 6 0 60 66 166 19 95 82 6
2020/2021502 52 0 108 47 37 51 9 16 5 63 76 38
2021/2022497 5 28 8 25 23 1 25 14 26 113 65 164
2022/20231.384 100 105 63 122 99 138 13 86 592 9 39 18
2023/2024249 33 35 17 32 29 71 4 7 2 19 0 0
Totale 3.592